Pure Global AI
CDSCO UID IMP/IVD/2023/000036_ed6c759c66759810a1338570ea427bf2_0cd0a3b86c3ea1c3c750c316e42a9939

Syphilis (MAGLUMI® Syphilis )

SNIBE DIAGNOSTIC (India) Private Limited.Device Class Class DIndia CDSCOBrand: CLIA
VerifiedCDSCO · official registry
Registration details
UID
IMP/IVD/2023/000036_ed6c759c66759810a1338570ea427bf2_0cd0a3b86c3ea1c3c750c316e42a9939
Device class
Class D
Brand name
CLIA
Approving authority
CDSCO
Product information
The kit is an in vitro chemiluminescent immunoassay for the qualitative determination of total antibodies against Treponema pallidum (CLIA) in human serum and plasma.
About this record

Syphilis (MAGLUMI® Syphilis ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000036_ed6c759c66759810a1338570ea427bf2_0cd0a3b86c3ea1c3c750c316e42a9939. This device is marketed under the brand name CLIA. The license holder is SNIBE DIAGNOSTIC (India) Private Limited., and it is classified as Device Class Class D. The approving authority is CDSCO.

This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.